Gilead and Galapagos Announce TORTUGA Phase 2 Study of Filgotinib in Ankylosing Spondylitis Achieves Primary Endpoint Read more
LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the United States Read more
Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Read more
Tolero Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial Read more
CNDA grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer Read more
Eisai And Merck Announce FDA Approval Of LENVIMA Capsules For Treatment Of Unresectable HCC Read more